- RecruitingPHASE3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
This study looks at a new medicine called mezagitamab for a kidney problem called IgA nephropathy. It compares mezagitamab to a dummy medicine to see if it lowers protein in the urine and helps protect kidneys. All adults over 18 with this condition can take part.
For: Kidney DiseaseUnited States · Argentina · Australia - RecruitingPHASE3
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
This study is testing a new medicine, mezagitamab, for adults with a bleeding condition called ITP. We want to see if it helps keep platelet counts stable. It's given by injection under the skin.
For: Immune Thrombocytopenic Purpura (ITP)United States · Australia · Bulgaria - RecruitingPHASE3
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
This study looks at how safe and effective a medicine called mezagitamab is for adults with a bleeding condition called ITP. If you’ve been in a previous mezagitamab study, you might be invited to join this longer follow-up.
For: Immune Thrombocytopenic Purpura (ITP)United States · Australia · Bulgaria